biotech / news / / Daily Excelsior
The Regeneron Global Capability Centre (GCC) will support the company’s mission of bringing new medicines to patients.
Regeneron Pharmaceuticals will establish a Global Capability Centre (GCC) in Hyderabad, operational by late 2026.
KEY POINTS
- The Regeneron GCC will create hundreds of new roles across data, AI, clinical trial operations, and more.
- This Hyderabad GCC is Regeneron's first such centre in India, enhancing their global operations footprint.
- The facility will support medicine development and strengthen Hyderabad's status as a life sciences hub.
COMPANIES
Summarized by Newsio from Daily Excelsior. How we summarize →